[go: up one dir, main page]

HRP20100189T1 - Farmaceutske formulacije koje sadrže supstancije za korekciju okusa sa poboljšanim farmaceutskim svojstvima - Google Patents

Farmaceutske formulacije koje sadrže supstancije za korekciju okusa sa poboljšanim farmaceutskim svojstvima Download PDF

Info

Publication number
HRP20100189T1
HRP20100189T1 HR20100189T HRP20100189T HRP20100189T1 HR P20100189 T1 HRP20100189 T1 HR P20100189T1 HR 20100189 T HR20100189 T HR 20100189T HR P20100189 T HRP20100189 T HR P20100189T HR P20100189 T1 HRP20100189 T1 HR P20100189T1
Authority
HR
Croatia
Prior art keywords
solid pharmaceutical
colloidal silicon
weight
pharmaceutical formulation
silicon dioxide
Prior art date
Application number
HR20100189T
Other languages
English (en)
Croatian (hr)
Inventor
Bosch Patrick
Bongaerts Sabine
Kanikanti Venkata-Rangarao
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of HRP20100189T1 publication Critical patent/HRP20100189T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20100189T 2003-11-04 2004-10-30 Farmaceutske formulacije koje sadrže supstancije za korekciju okusa sa poboljšanim farmaceutskim svojstvima HRP20100189T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10351448A DE10351448A1 (de) 2003-11-04 2003-11-04 Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
PCT/EP2004/012327 WO2005044271A1 (de) 2003-11-04 2004-10-30 Geschmacksstoffhaltige arzneimittelformulierungen mit verbesserten pharmazeutischen eigenschaften

Publications (1)

Publication Number Publication Date
HRP20100189T1 true HRP20100189T1 (hr) 2010-05-31

Family

ID=34559323

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100189T HRP20100189T1 (hr) 2003-11-04 2004-10-30 Farmaceutske formulacije koje sadrže supstancije za korekciju okusa sa poboljšanim farmaceutskim svojstvima

Country Status (30)

Country Link
US (2) US7858120B2 (uk)
EP (2) EP1682144B1 (uk)
JP (1) JP4892351B2 (uk)
KR (2) KR101325146B1 (uk)
CN (2) CN1972687B (uk)
AR (2) AR046226A1 (uk)
AT (1) ATE454891T1 (uk)
AU (1) AU2004286785B2 (uk)
BR (1) BRPI0416188A (uk)
CA (1) CA2544344C (uk)
CR (1) CR8371A (uk)
CY (2) CY1110541T1 (uk)
DE (2) DE10351448A1 (uk)
DK (1) DK1682144T3 (uk)
ES (1) ES2337793T3 (uk)
HR (1) HRP20100189T1 (uk)
IL (1) IL175147A (uk)
LU (1) LU91882I2 (uk)
MY (1) MY149864A (uk)
NO (1) NO339326B1 (uk)
NZ (1) NZ546921A (uk)
PE (1) PE20050575A1 (uk)
PL (1) PL1682144T3 (uk)
PT (1) PT1682144E (uk)
RU (1) RU2377018C2 (uk)
SI (1) SI1682144T1 (uk)
TW (1) TWI343819B (uk)
UA (1) UA85691C2 (uk)
WO (1) WO2005044271A1 (uk)
ZA (1) ZA200603451B (uk)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
DE102007004732A1 (de) * 2007-01-31 2008-08-07 Bayer Healthcare Ag Enrofloxacin-Hexahydrat
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
GB0722484D0 (en) * 2007-11-15 2007-12-27 Ucl Business Plc Solid compositions
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
US20110223297A1 (en) * 2010-03-12 2011-09-15 Pepsico., Inc. Anti-Caking Agent for Flavored Products
US10543170B2 (en) * 2012-12-19 2020-01-28 Bayer Animal Health Gmbh Tablets with improved acceptance and good storage stability
WO2015042596A1 (en) * 2013-09-23 2015-03-26 Kindred Biosciences, Inc Treatment of atopic dermatitis in non-human animals
TWI727036B (zh) * 2016-04-27 2021-05-11 日商富山化學工業股份有限公司 包含甲苯磺酸托氟沙星、崩解劑及酸性胺基酸之錠劑
WO2017188361A1 (ja) * 2016-04-27 2017-11-02 富山化学工業株式会社 トスフロキサシントシル酸塩を含む錠剤
CN105997908B (zh) * 2016-06-03 2019-06-21 湖北回盛生物科技有限公司 一种马波沙星牛肉风味片及其制备方法
AU2019260015C1 (en) 2018-04-25 2024-11-21 Elanco Animal Health Gmbh Process for the hydrolysis of quinolone carboxylic esters

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA413698A (en) * 1943-07-06 Frederick Dauster John Breathing valve
JPS5746986A (en) 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4472405A (en) 1982-11-12 1984-09-18 Riker Laboratories, Inc. Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives
US4730000A (en) 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
AT392789B (de) 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
IN166416B (uk) 1985-09-18 1990-05-05 Pfizer
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US4910023A (en) * 1988-06-09 1990-03-20 Warner-Lambert Company Drug in combination with flavor masking agent and method for making same
GB8824392D0 (en) * 1988-10-18 1988-11-23 Ciba Geigy Ag Dispersible formulation
US5256699A (en) * 1988-10-18 1993-10-26 Ciba-Geify Corporation Dispersible tablet formulation of diclofenac acid free base
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
EP1166801A1 (en) * 1993-06-04 2002-01-02 Warner-Lambert Company Preparations containing silicon dioxide to improve the taste thereof
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5789434A (en) 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
PT725037E (pt) * 1995-02-04 2001-07-31 Degussa Granulados a base de dioxido de silicio preparado pirogenicamente processo para a sua preparacao e sua utilizacao
HU228036B1 (en) 1996-02-23 2012-08-28 Bayer Animal Health Gmbh Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4,3,0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives, process producing them and medicaments thereof
US20010018417A1 (en) * 1996-07-01 2001-08-30 Carson James W. Virginiamycin mixture
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
CA2216215A1 (en) * 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
US6607754B1 (en) * 1997-07-11 2003-08-19 Upsher-Smith Laboratories, Inc. Delivery of Hypericum perforatum (St. John's Wort) in tablet form
JP2002505269A (ja) * 1998-03-06 2002-02-19 エウランド インターナショナル ソシエタ ペル アチオニ 急速崩壊錠剤
US6419953B1 (en) * 1998-12-18 2002-07-16 Abbott Laboratories Controlled release formulation of divalproex sodium
HU227070B1 (en) 1999-08-11 2010-06-28 Egis Gyogyszergyar Nyilvanosan Immediate release pharmaceutical composition containing ciprofloxacin and process for its production
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
PL365071A1 (en) 2000-03-03 2004-12-27 Ranbaxy Laboratories Limited Orally administered controlled delivery system for once daily administration of ciprofloxacin
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
ES2185452B2 (es) * 2000-08-01 2004-03-16 Cinfa S A Lab Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
EP1247456A3 (en) * 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
GB0123400D0 (en) * 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
US20030170310A1 (en) * 2002-03-08 2003-09-11 Hardeep Wadhwa Tasteless, directly compressible, fast-dissolving complexes and pharmaceutical formulations thereof
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10250711A1 (de) 2002-10-31 2004-05-19 Degussa Ag Pharmazeutische und kosmetische Zubereitungen
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DK2498756T4 (da) * 2009-11-09 2023-03-20 Wyeth Llc Tabletformuleringer af neratinibmaleat

Also Published As

Publication number Publication date
ES2337793T3 (es) 2010-04-29
EP1682144B1 (de) 2010-01-13
AR108594A2 (es) 2018-09-05
CY2011017I2 (el) 2016-12-14
RU2377018C2 (ru) 2009-12-27
UA85691C2 (uk) 2009-02-25
CR8371A (es) 2006-10-10
JP2007510001A (ja) 2007-04-19
US20070196466A1 (en) 2007-08-23
CN1972687A (zh) 2007-05-30
DE10351448A1 (de) 2005-06-09
BRPI0416188A (pt) 2007-01-23
WO2005044271A1 (de) 2005-05-19
HK1107008A1 (en) 2008-03-28
CA2544344C (en) 2013-10-15
ATE454891T1 (de) 2010-01-15
EP1682144A1 (de) 2006-07-26
PL1682144T3 (pl) 2010-06-30
US7858120B2 (en) 2010-12-28
CY1110541T1 (el) 2015-04-29
DE502004010644D1 (de) 2010-03-04
NZ546921A (en) 2009-08-28
AU2004286785B2 (en) 2010-08-12
KR20060109910A (ko) 2006-10-23
LU91882I2 (fr) 2013-04-12
CN1972687B (zh) 2013-01-23
DK1682144T3 (da) 2010-05-17
JP4892351B2 (ja) 2012-03-07
AU2004286785A8 (en) 2009-08-13
NO339326B1 (no) 2016-11-28
TW200517144A (en) 2005-06-01
NO20062605L (no) 2006-07-25
RU2006119294A (ru) 2007-12-27
EP2080515A1 (de) 2009-07-22
ZA200603451B (en) 2007-07-25
KR101325146B1 (ko) 2013-11-07
TWI343819B (en) 2011-06-21
US20110065719A1 (en) 2011-03-17
CN102335117A (zh) 2012-02-01
AR046226A1 (es) 2005-11-30
IL175147A0 (en) 2008-04-13
KR20120093299A (ko) 2012-08-22
SI1682144T1 (sl) 2010-05-31
PE20050575A1 (es) 2005-10-27
CA2544344A1 (en) 2005-05-19
AU2004286785A1 (en) 2005-05-19
IL175147A (en) 2014-04-30
PT1682144E (pt) 2010-03-09
MY149864A (en) 2013-10-31
CY2011017I1 (el) 2016-12-14

Similar Documents

Publication Publication Date Title
HRP20100189T1 (hr) Farmaceutske formulacije koje sadrže supstancije za korekciju okusa sa poboljšanim farmaceutskim svojstvima
ES2350029T3 (es) Pellets de liberación sostenida que comprenden un material tipo cera.
US20050147672A1 (en) Tablets quickly disintegrating in mouth
JP6110065B2 (ja) 血を吸うおよび血を消費する寄生生物の、殺寄生生物剤の経口投与による全身処置
BRPI0820520B8 (pt) processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos
US10426725B2 (en) Self-supporting films for pharmaceutical and food use
CN106999421A (zh) 适口的可咀嚼兽用组合物
KR20090113777A (ko) 불쾌한 맛을 은폐한 경구 조성물
BRPI0417043A (pt) composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
CN114144172A (zh) 软咀嚼兽用剂型
WO2007067582A3 (en) Process for manufacturing chewable dosage forms for drug delivery and products thereof
HUP0105173A2 (hu) Adagolási módszer és készítmény sürgősségi fogamzásgátlásra
JP2013525340A (ja) フェキソフェナジンを主成分とする組成物及びその製造方法
CN101927002A (zh) 一种药物涂层组合物
DK1561460T3 (da) Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det samme
CZ20022886A3 (cs) Prostředek proti endoparasitům
US20150072014A1 (en) Pharmaceutical Compositions of Sodium Picosulfate, Magnesium Oxide and Citric Acid
CA2380757A1 (en) Pharmaceutical agent comprising a benzamide derivative as active ingredient
EA012324B1 (ru) Быстрораспадающаяся таблетка
EA200500671A1 (ru) Фармацевтический состав оланзапина
Gururajbhat et al. A comprehensive review on formulation, preparation, evaluation and applications of Medicated Chewing Gum
DE60319983D1 (de) Universelle Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend Chitosan
AU2002337517A2 (en) Tablet delivery system
JP5054940B2 (ja) 錠剤組成物
JP2001072578A (ja) 口腔内速崩壊錠